Lead Product(s) : Armodafinil
Therapeutic Area : Sleep
Study Phase : Undisclosed
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Sleep Apnea Syndromes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 17, 2015
Lead Product(s) : Armodafinil
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Stroke.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 11, 2013
Lead Product(s) : Armodafinil
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Sleep
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Narcolepsy.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 20, 2012
Lead Product(s) : Armodafinil
Therapeutic Area : Sleep
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Menopause.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 27, 2011
Lead Product(s) : Armodafinil
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Glioma.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 25, 2011
Lead Product(s) : Armodafinil
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Depression.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 28, 2011
Lead Product(s) : Armodafinil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 09, 2010
Lead Product(s) : Armodafinil
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 26, 2010
Lead Product(s) : Armodafinil
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Fatigue.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 12, 2010
Lead Product(s) : Armodafinil
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Armodafinil is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Depression.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 12, 2010
Lead Product(s) : Armodafinil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
